Al Mayadeen English

  • Ar
  • Es
  • x
Al Mayadeen English

Slogan

  • News
    • Politics
    • Economy
    • Sports
    • Arts&Culture
    • Health
    • Miscellaneous
    • Technology
    • Environment
  • Articles
    • Opinion
    • Analysis
    • Blog
    • Features
  • Videos
    • NewsFeed
    • Video Features
    • Explainers
    • TV
    • Digital Series
  • Infographs
  • In Pictures
  • • LIVE
News
  • Politics
  • Economy
  • Sports
  • Arts&Culture
  • Health
  • Miscellaneous
  • Technology
  • Environment
Articles
  • Opinion
  • Analysis
  • Blog
  • Features
Videos
  • NewsFeed
  • Video Features
  • Explainers
  • TV
  • Digital Series
Infographs
In Pictures
  • Africa
  • Asia
  • Asia-Pacific
  • Europe
  • Latin America
  • MENA
  • Palestine
  • US & Canada
BREAKING
US President Donald Trump: “I think we’re going to have a deal on Gaza very soon."
Yemeni Armed Forces spokesman announced an attack against a vital target in Askalan with a drone and attacked al-Lyd Airport with another drone.
Yemeni Armed Forces spokesman announced an operation with 3 drones against 2 sensitive targets in Al-Naqab.
Yemeni Armed Forces said it targeted several targets in the al-Naqab, Umm al-Rashrash/Eilat, occupied Askalan, Asdud, and Yafa with several drones.
Israeli Channel 12: Drone launched from Yemen which struck passenger lounge in Ramon Airport, two injured.
Presidium: We have a very urgent resolution, and if general principles and details approved, it will be discussed in public session.
Spokesperson of Presidium: Guardian Council members will attend Parliament tomorrow during discussions for resolution on NPT withdrawal.
Iran's parliamentary presidium: We will look today into parliamentary National Security Committee's recommendations on withdrawal from NPT.
Ukrainian media: Fire in Ukrainian government building in Kiev.
Trump signs executive order on changing name of Department of Defense to Department of War

Johnson & Johnson investigated in South Africa for high TB drug price

  • By Al Mayadeen English
  • Source: News websites
  • 22 Sep 2023 13:52
4 Min Read

South Africa records one of the highest TB rates in the world, and although it is curable, it ranks as the country’s top cause of death.

  • x
  • The number of tablets taken as part of the new treatment, which includes bedaquiline, as opposed to the old (AFP)
    The number of tablets taken as part of the new treatment, which includes bedaquiline (L), as opposed to the old (R). (AFP)

The US drugmaker Johnson & Johnson is being subject to an investigation by South Africa’s Competition Commission as a result of the high prices set for tuberculosis (TB) medicine named bedaquiline, in addition to its decision for its 20-year patent until 2027 to prevent cheaper generics from entering the country.

The investigation was revealed to the public at a media briefing of Médecins Sans Frontières (MSF) last week by the country's health department and the Health Justice Initiative (HJI) legal organization.

The patent refers to that for bedaquiline compounds in South Africa, which expired in July but was extended to 2027, prompting accusations against J&J of evergreening - which means when pharmaceutical manufacturers make trivial alterations to medicines or their applications to keep their monopoly on the market.

The founder, and director of HJI, Fatima Hassan, said, "The Competition Commission believes J&J could be in contravention of Section 8 of the Competition Act, which deals with excessive pricing and exclusionary conduct, which, in this case, refers to the practice of evergreening [because it results in excluding others from the market]," adding: "We believe this is unprecedented. We do not know of other investigations by the Competition Commission into a pharmaceutical company for evergreening."

It is false to suggest—as some recently have—that our patents are being used to prevent access to SIRTURO® (bedaquiline), our medicine for MDR-TB.

In fact, we have already entered into a collaboration with the Stop TB Partnership’s Global Drug Facility ("GDF")—the largest… pic.twitter.com/3pYy8AYhYW

— Johnson & Johnson (@JNJNews) July 12, 2023

Suffer more, pay more

South Africa records one of the highest TB rates in the world, and although it is curable, it ranks as the country’s top cause of death.

Related News

Maduro deploys 25,000 troops to Colombia border, Caribbean coast

Hamas confirms receiving US proposal for Gaza ceasefire

Bedaquiline, alongside a combination of other drugs, intends to treat multidrug-resistant TB, which is not treatable with regular remedies. A gamechanger, bedaquiline challenges previous treatment, which consisted of two years of painful injections carrying side-effects, such as hearing loss and a high death rate.

The drug, required to be taken for a duration of six months, is already being given by the health department to the public in need since 2018.

'J&J prioritizes profit over needs of vulnerable'

Currently, the health department purchases the six-month course for each patient in need at 5,400 rand ($286), but starting October 1, when the new contract with the manufacturer begins, it will become 5,500 rand ($290). Meanwhile, nations that purchase it through the Stop TB partnership’s Global Drug Facility only pay around 2,446 rand ($129) - less than half. 

The Global Drug Facility uses pooled procurement for payment negotiation, which makes bargaining for lower prices for TB medicines possible, but those like South Africa, with open tender systems, are not legally able to purchase it through such systems.

Candice Sehoma of MSF expressed: "We are enraged to witness that J&J prioritizes profit over the needs of the most vulnerable populations in a country with a high burden of drug-resistant TB," urging "J&J to offer the same price of 2,446 rand for bedaquiline to the South African government as they have offered to countries that are part of the Global Drug Facility deal."

'Addressing health inequities'

Health activists have been calling for the past 10 years for a change in the legislation to contain evergreening.

Russell Rensburg, the director of the Rural Health Advocacy Project at Wits University in Johannesburg, explained: "Something for our legislators to consider is why we haven’t fixed our [patent] laws to ensure we don’t expose ourselves to these kinds of exploitative practices. Fixing the patent laws is essential to addressing health inequity."

In light of this, global leaders are partaking in a high-level discussion this week at the United Nations General Assembly in New York for the fight against TB, and discuss practices such as evergreening.

In its statement, the Competition Commission informed Johnson & Johnson of its investigation: "Johnson & Johnson is a longstanding and committed partner in South Africa’s fight against multidrug-resistant tuberculosis. Today, all patients in South Africa who require bedaquiline, our medicine for multidrug-resistant tuberculosis, have access to it thanks to our collaboration with the government of South Africa and other partners, which has contributed to a steady decline in TB incidence."

"We will continue to work collaboratively with our partners to ensure we can achieve our shared goal of ending TB," the company further said.

  • United States
  • Tuberculosis
  • South Africa
  • Johnson & Johnson

Most Read

Al Mayadeen English

Hezbollah’s weapons and the lessons of Syria, PLO, and Algeria

  • Politics
  • 2 Sep 2025
This Jan. 31, 2019 file photo, shows an oil platform in the Leviathan natural gas field, in the Mediterranean Sea off the Palestinian coast. (AP)

Netanyahu freezes $35 bln gas deal with Egypt over troops in Sinai

  • Politics
  • 2 Sep 2025
The Coming War On Iran Will Be Regional, Perhaps International

The coming war on Iran will be regional, perhaps international

  • Opinion
  • 2 Sep 2025
Why Russia and China are NOT Imperialist: A Marxist-Leninist Assessment of Imperialism’s Development Since 1917

Why Russia and China are NOT Imperialist: A Marxist-Leninist Assessment of Imperialism’s Development Since 1917

  • Analysis
  • 4 Sep 2025

Coverage

All
The Ummah's Martyrs

Read Next

All
Iran's Leader Sayyed Ali Khamenei waves as he arrives for a ceremony marking the anniversary of the death of the late leader Sayyed Ruhollah Khomeini at his shrine just outside Tehran, Iran, Wednesday, June 4, 2025 (AP)
Politics

Sayyed Khamenei calls for prioritizing economy, national unity

Palestinians line up to receive donated food at a community kitchen in Deir al-Balah, southern Gaza Strip, Saturday, September 6, 2025 (AP)
Politics

HRW urges arms embargo on Israeli regime amid Gaza famine crisis

Blackwater founder Erik Prince speaks at the Conservative Political Action Conference, CPAC, at the Gaylord National Resort & Convention Center, Saturday, Feb. 22, 2025, in Oxon Hill, Md. (AP Photo/Jose Luis Magana)
Politics

Blackwater founder seeks to acquire Ukrainian drone companies: report

Brigadier General Yahya Saree, the spokesperson of the Yemeni Armed Forces, announces a military operation against several targets in occupied Palestine, September 7, 2025 (Yemeni Military Media)
Politics

YAF announce major drone op. against multiple Israeli targets

Al Mayadeen English

Al Mayadeen is an Arab Independent Media Satellite Channel.

All Rights Reserved

  • x
  • Privacy Policy
  • About Us
  • Contact Us
  • Authors
Android
iOS